ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $119M (100.0% shares, 0.0% debt)

Holdings (33)

OCUL OCULAR THERAPEUTIX INC 16.0%

Value $18.95M Shares 2,771,130 Est. Cost $5.09 Unrealized +21.2%

ELVN ENLIVEN THERAPEUTICS INC 7.8%

Value $9.294M Shares 397,698 Est. Cost $16.47 Unrealized +27.8%

PCVX VAXCYTE INC 7.0%

Value $8.336M Shares 110,400 Est. Cost $33.15 Unrealized +105.3%

DYN DYNE THERAPEUTICS INC 6.3%

Value $7.499M Shares 212,500 Est. Cost $15.58 Unrealized +86.5%

PRAX PRAXIS PRECISION MEDICINES I 5.7%

Value $6.801M Shares 164,431 Est. Cost $18.39 Unrealized +157.0%

CRNX CRINETICS PHARMACEUTICALS 5.1%

Value $6.053M Shares 135,141 Est. Cost $31.34 Unrealized +47.3%

RCKT ROCKET PHARMACEUTICALS INC 4.5%

Value $5.39M Shares 250,370 Est. Cost $18.58 Unrealized +23.6%

TSHA TAYSHA GENE THERAPIES INC 4.4%

Value $5.221M Shares 2,330,937 Est. Cost $1.87 Unrealized +55.8%

RVMD REVOLUTION MEDICINES INC 4.3%

Value $5.162M Shares 133,000 Est. Cost $24.03 Unrealized +55.5%

INSM INSMED INC 4.1%

Value $4.831M Shares 72,100 Est. Cost $28.70 Unrealized +35.1%

SRPT SAREPTA THERAPEUTICS INC 3.7%

Value $4.345M Shares 27,500 Est. Cost $99.68 Unrealized +28.9%

— TOURMALINE BIO INC 2.9%

Value $3.467M Shares 269,614 Est. Cost $25.40 Unrealized —

AGIO AGIOS PHARMA 2.9%

Value $3.394M Shares 78,700 Est. Cost $29.55 Unrealized +22.1%

KURA KURA ONCOLOGY INC. COMMON STOCK 2.8%

Value $3.356M Shares 163,000 Est. Cost $17.02 Unrealized +20.8%

— MERSANA THERAPEUTICS INC 2.8%

Value $3.343M Shares 1,663,000 Est. Cost $2.28 Unrealized —

CRBP CORBUS PHARMACEUTICALS HOLDI 2.5%

Value $2.919M Shares 64,500 Est. Cost $42.06 Unrealized 0.0%

WHWK AADI BIOSCIENCES INC 2.3%

Value $2.7M Shares 1,849,402 Est. Cost $27.48 Unrealized -93.3%

VRDN VIRIDIAN THERAPEUTICS INC 2.2%

Value $2.595M Shares 199,433 Est. Cost $19.02 Unrealized -27.2%

TERN TERNS PHARMACEUTICALS INC 2.1%

Value $2.515M Shares 369,280 Est. Cost $5.72 Unrealized +5.9%

MREO MEREO BIOPHARMA GROUP PL-ADR 2.1%

Value $2.437M Shares 677,000 Est. Cost $3.42 Unrealized —

ACLX ARCELLX INC 2.0%

Value $2.329M Shares 42,200 Est. Cost $46.80 Unrealized +16.2%

BBOT HELIX ACQUISITION CORP II 1.5%

Value $1.817M Shares 177,836 Est. Cost $10.29 Unrealized 0.0%

ARGX ARGENX SE 1.4%

Value $1.72M Shares 4,000 Est. Cost $430.04 Unrealized —

TRVI TREVI THERAPEUTICS INC 0.7%

Value $775K Shares 260,000 Est. Cost $2.78 Unrealized 0.0%

CELC CELCUITY INC 0.6%

Value $737K Shares 45,000 Est. Cost $16.73 Unrealized 0.0%

ORIC ORIC PHARMACEUTICALS INC 0.6%

Value $679K Shares 96,000 Est. Cost $11.88 Unrealized -24.6%

PLRX PLIANT THERAPEUTICS INC 0.4%

Value $497K Shares 46,200 Est. Cost $12.89 Unrealized 0.0%

RAPP RAPPORT THERAPEUTICS INC 0.4%

Value $465K Shares 20,000 Est. Cost $23.15 Unrealized 0.0%

NAMS NEWAMSTERDAM PHARMA CO NV 0.4%

Value $432K Shares 22,500 Est. Cost $20.06 Unrealized 0.0%

CYPH LEAP THERAPEUTICS INC 0.3%

Value $382K Shares 195,000 Est. Cost $2.32 Unrealized +12.8%

— CELLECTAR BIOSCIENCES INC. 0.1%

Value $176K Shares 70,500 Est. Cost $2.74 Unrealized —

SVRA SAVARA INC 0.1%

Value $101K Shares 250 Est. Cost — Unrealized —

— NUVATION BIO INC -CW27 0.0%

Value $14,533 Shares 90,832 Est. Cost $0.28 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
OCUL	OCULAR THERAPEUTIX INC	2,771,130	$18.95M	16.0%	$5.09	+21.2%	COM	67576A100
ELVN	ENLIVEN THERAPEUTICS INC	397,698	$9.294M	7.8%	$16.47	+27.8%	COM	29337E102
PCVX	VAXCYTE INC	110,400	$8.336M	7.0%	$33.15	+105.3%	COM	92243G108
DYN	DYNE THERAPEUTICS INC	212,500	$7.499M	6.3%	$15.58	+86.5%	COM	26818M108
PRAX	PRAXIS PRECISION MEDICINES I	164,431	$6.801M	5.7%	$18.39	+157.0%	COM	74006W207
CRNX	CRINETICS PHARMACEUTICALS	135,141	$6.053M	5.1%	$31.34	+47.3%	COM	22663K107
RCKT	ROCKET PHARMACEUTICALS INC	250,370	$5.39M	4.5%	$18.58	+23.6%	COM	77313F106
TSHA	TAYSHA GENE THERAPIES INC	2,330,937	$5.221M	4.4%	$1.87	+55.8%	COM SHS	877619106
RVMD	REVOLUTION MEDICINES INC	133,000	$5.162M	4.3%	$24.03	+55.5%	COM	76155X100
INSM	INSMED INC	72,100	$4.831M	4.1%	$28.70	+35.1%	COM PAR $.01	457669307
SRPT	SAREPTA THERAPEUTICS INC	27,500	$4.345M	3.7%	$99.68	+28.9%	COM	803607100
—	TOURMALINE BIO INC	269,614	$3.467M	2.9%	$25.40	—	COM	89157D105
AGIO	AGIOS PHARMA	78,700	$3.394M	2.9%	$29.55	+22.1%	COM	00847X104
KURA	KURA ONCOLOGY INC. COMMON STOCK	163,000	$3.356M	2.8%	$17.02	+20.8%	COM	50127T109
—	MERSANA THERAPEUTICS INC	1,663,000	$3.343M	2.8%	$2.28	—	COM	59045L106
CRBP	CORBUS PHARMACEUTICALS HOLDI	64,500	$2.919M	2.5%	$42.06	0.0%	COM NEW	21833P301
WHWK	AADI BIOSCIENCES INC	1,849,402	$2.7M	2.3%	$27.48	-93.3%	COM	00032Q104
VRDN	VIRIDIAN THERAPEUTICS INC	199,433	$2.595M	2.2%	$19.02	-27.2%	COM	92790C104
TERN	TERNS PHARMACEUTICALS INC	369,280	$2.515M	2.1%	$5.72	+5.9%	COM	880881107
MREO	MEREO BIOPHARMA GROUP PL-ADR	677,000	$2.437M	2.1%	$3.42	—	SPON ADS	589492107
ACLX	ARCELLX INC	42,200	$2.329M	2.0%	$46.80	+16.2%	COMMON STOCK	03940C100
BBOT	HELIX ACQUISITION CORP II	177,836	$1.817M	1.5%	$10.29	0.0%	CL A ORD SHS	G4444H101
ARGX	ARGENX SE	4,000	$1.72M	1.4%	$430.04	—	SPONSORED ADR	04016X101
TRVI	TREVI THERAPEUTICS INC	260,000	$775K	0.7%	$2.78	0.0%	COM	89532M101
CELC	CELCUITY INC	45,000	$737K	0.6%	$16.73	0.0%	COM	15102K100
ORIC	ORIC PHARMACEUTICALS INC	96,000	$679K	0.6%	$11.88	-24.6%	COM	68622P109
PLRX	PLIANT THERAPEUTICS INC	46,200	$497K	0.4%	$12.89	0.0%	COM	729139105
RAPP	RAPPORT THERAPEUTICS INC	20,000	$465K	0.4%	$23.15	0.0%	COM	75383L102
NAMS	NEWAMSTERDAM PHARMA CO NV	22,500	$432K	0.4%	$20.06	0.0%	ORDINARY SHARES	N62509109
CYPH	LEAP THERAPEUTICS INC	195,000	$382K	0.3%	$2.32	+12.8%	COM NEW	52187K200
—	CELLECTAR BIOSCIENCES INC.	70,500	$176K	0.1%	$2.74	—	COM NEW	15117F807
SVRA	SAVARA INC	250	$101K	0.1%	—	—	Put	805111101
—	NUVATION BIO INC -CW27	90,832	$14,533	0.0%	$0.28	—	*W EXP 07/07/2027	67080N119